article

European Pharmaceutical Review Issue 4 2021

In our latest issue, features explore the use of nano formulations to improve skin and nail drug delivery, how to take cell and gene therapies from concept to commercialisation and what strategies you can use to overcome interfering factors in LAL bacterial endotoxin testing. Also in this journal, find out why value-added medicines can compliment new molecular entity development in evolving your drug pipeline and how the potential of therapeutic antibodies could be realised by rethinking their development, manufacture and delivery.

EPR 421 Featured Image(750x500)

Feature articles in issue 4 2021:

  • FORMULATION, DEVELOPMENT & DELIVERY
    Improving infusion dosing accuracy for patient safety
    Emmelyn Graham, TÜV SÜD National Engineering Laboratory, and Elsa Batista, Portuguese Institute for Quality (IPQ)
  • QA/QC ENVIRONMENTAL MONITORING
    Scrubbing up the environment
    Kevin P Griffiths, Kayleigh Clark, Rhiannon McCarroll and Sean Fradgley, University Hospitals Bristol and Weston NHS Foundation Trust (UHBW)
  • COVID-19
    The research-based industry response to COVID-19; collaboration and innovation
    Nathalie Moll, European Federation of Pharmaceutical Industries and Associations (EFPIA)
  • BIOPROCESSING & BIOPRODUCTION
    Principal component analysis of Raman spectra for freeze-drying process monitoring
    Lukas Kuerten, CPI Biologics, and Rachel Findlay, CPI Formulation
  • MANUFACTURING, PACKAGING & LOGISTICS
    UK at the forefront of advanced therapies
    Rachel Bell, Marks & Clerk, and Ceri Roberts, NHS Blood and Transplant

The rest of this content is restricted - login or subscribe free to access

EPR Issue 1 2024Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here